Sjogren's Syndrome: More Than Just Dry Eye

被引:94
作者
Akpek, Esen K. [1 ]
Bunya, Vatinee Y. [2 ]
Saldanha, Ian J. [3 ]
机构
[1] Johns Hopkins Sch Med, Wilmer Eye Inst, Baltimore, MD USA
[2] Univ Penn, Scheie Eye Inst, Philadelphia, PA 19104 USA
[3] Brown Univ, Sch Publ Hlth, Ctr Evidence Synth Hlth, Dept Hlth Serv Policy & Practice, Providence, RI 02912 USA
关键词
Sjogren's syndrome; dry eye; extraglandular symptoms; underdiagnosis; CLASSIFICATION CRITERIA; LYMPHOMA DEVELOPMENT; CORNEAL PERFORATION; AMERICAN-COLLEGE; DATA-DRIVEN; RISK; AUTOIMMUNE; CONSENSUS; PATIENT; KERATOPLASTY;
D O I
10.1097/ICO.0000000000001865
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: Sjogren's syndrome (SS) is a common autoimmune disease affecting about four million Americans. Although approximately 1 in 10 patients with clinically-significant aqueous deficient dry eye has underlying SS, widespread underappreciation of SS leads to significant underdiagnosis, delays in diagnosis, and consequent morbidity and mortality. The purpose of this article is to illustrate that in addition to dry eye, SS can cause serious, visionthreatening extraglandular ocular manifestations. Methods: We conducted a narrative review of studies that have examined the dry eye and extraglandular ocular complications of SS. Results: SS-related dry eye is a progressive condition with major negative impact on the quality-of-life of afflicted patients, not only due to symptoms of ocular discomfort but also visual dysfunction. In addition, SS can lead to corneal melt/perforation, uveitis, scleritis, retinal vasculitis, and optic neuritis. A major problem with currently-available SS disease activity measurement instruments is the lack of domains evaluating dry eye-related visual dysfunction. For example, one of the most commonlyused instruments for assessing patient symptoms in SS (the EULAR Sjogren's Syndrome Patient Reported Index [ ESSPRI]) only includes one item (out of three) that addresses the severity of overall dryness, without mention of dry eye symptoms or vision-related quality-of-life. Similarly, no extraglandular ocular complications are included in currently-available SS disease activity instruments (e.g., the EULAR Sjogren's Syndrome Disease Activity Index [ ESSDAI]). Conclusions: There needs to be a paradigm shift in which eye care providers and rheumatologists become more familiar with various SS-related extraglandular ocular manifestations. Existing disease activity measurement instruments must incorporate dry eye symptoms, particularly those related to visual dysfunction. An evidencebased screening algorithm for determining which patients with dry eye should be tested for underlying SS may be particularly helpful in preventing delays in diagnosis.
引用
收藏
页码:658 / 661
页数:4
相关论文
共 43 条
  • [1] Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sjogren's syndrome
    Adatia, FA
    Michaeli-Cohen, A
    Naor, J
    Caffery, B
    Bookman, A
    Slomovic, A
    [J]. CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2004, 39 (07): : 767 - 771
  • [2] Successful treatment of refractory anterior scleritis in primary Sjogren's syndrome with rituximab
    Ahmadi-Simab, K
    Lamprecht, P
    Nölle, B
    Ai, M
    Gross, WL
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (07) : 1087 - 1088
  • [3] Ocular and Systemic Morbidity in a Longitudinal Cohort of Sjogren's Syndrome
    Akpek, Esen Karamursel
    Mathews, Priya
    Hahn, Sarah
    Hessen, Michelle
    Kim, Jean
    Grader-Beck, Thomas
    Birnbaum, Julius
    Baer, Alan N.
    [J]. OPHTHALMOLOGY, 2015, 122 (01) : 56 - 61
  • [4] Evaluation of Patients With Dry Eye for Presence of Underlying Sjogren Syndrome
    Akpek, Esen Karamursel
    Klimava, Alena
    Thorne, Jennifer E.
    Martin, Don
    Lekhanont, Kaevalin
    Ostrovsky, Ann
    [J]. CORNEA, 2009, 28 (05) : 493 - 497
  • [5] A Clinical Prediction Rule for Lymphoma Development in Primary Sjogren's Syndrome
    Baldini, Chiara
    Pepe, Pasquale
    Luciano, Nicoletta
    Ferro, Francesco
    Talarico, Rosaria
    Grossi, Sara
    Tavoni, Antonio
    Bombardieri, Stefano
    [J]. JOURNAL OF RHEUMATOLOGY, 2012, 39 (04) : 804 - 808
  • [6] Unusual presentation of a case of Sjogren's syndrome with neurological and ocular manifestation
    Bamrolia, Naina R.
    Arora, Ritu
    Yadava, Usha
    [J]. CONTACT LENS & ANTERIOR EYE, 2012, 35 (02) : 85 - 88
  • [7] ACUTE IRITIS ASSOCIATED WITH PRIMARY SJOGRENS-SYNDROME AND HIGH-TITER ANTI-SS-A/RO AND ANTI-SS-B/LA ANTIBODIES - TREATMENT WITH COMBINATION IMMUNOSUPPRESSIVE THERAPY
    BRIDGES, AJ
    BURNS, RP
    [J]. ARTHRITIS AND RHEUMATISM, 1992, 35 (05): : 560 - 563
  • [8] Advances in the understanding and treatment of systemic complications in Sjogren's syndrome
    Brito-Zeron, Pilar
    Ramos-Casals, Manuel
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2014, 26 (05) : 520 - 527
  • [9] Survey of Ophthalmologists Regarding Practice Patterns for Dry Eye and Sjogren Syndrome
    Bunya, Vatinee Y.
    Fernandez, Karen B.
    Ying, Gui-Shuang
    Massaro-Giordano, Mina
    Macchi, Ilaria
    Sulewski, Michael E.
    Hammersmith, Kristin M.
    Nagra, Parveen K.
    Rapuano, Christopher J.
    Orlin, Stephen E.
    [J]. EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2018, 44 : S196 - S201
  • [10] Choi Won, 2011, Korean J Ophthalmol, V25, P275, DOI 10.3341/kjo.2011.25.4.275